Abstract
About 300 of steroid drugs have been identified since the research and development to steroid drugs was triggered in 1950s. Although much progress in microbial biotransformation on steroid drugs is well-achieved, many efforts are ongoing in order to improve the efficiency of steroidal drug production as well as to degrade their derivatives. In this work an overview of recent and important findings related to patents and various microbial biotransformations of steroidal compounds including dehydrogenation/reduction, hydroxylation, esterification, methylation, halogenation and methoxylation is presented. Both metabolic pathway and genetic manipulation and screening for new strains capable of metabolizing/transforming steroid drugs, as the powerful endocrine disruptors, are introduced since they are serious environmental contaminants.
Keywords: Biodegradation, biotransformation, dehydrogenation, esterification, halogenations, hydroxylation, metabolic pathway, methylation, methoxylation, reduction
Recent Patents on Biotechnology
Title: Microbial Biotransformation: Recent Developments on Steroid Drugs
Volume: 3 Issue: 2
Author(s): Wang-Yu Tong and Xiang Dong
Affiliation:
Keywords: Biodegradation, biotransformation, dehydrogenation, esterification, halogenations, hydroxylation, metabolic pathway, methylation, methoxylation, reduction
Abstract: About 300 of steroid drugs have been identified since the research and development to steroid drugs was triggered in 1950s. Although much progress in microbial biotransformation on steroid drugs is well-achieved, many efforts are ongoing in order to improve the efficiency of steroidal drug production as well as to degrade their derivatives. In this work an overview of recent and important findings related to patents and various microbial biotransformations of steroidal compounds including dehydrogenation/reduction, hydroxylation, esterification, methylation, halogenation and methoxylation is presented. Both metabolic pathway and genetic manipulation and screening for new strains capable of metabolizing/transforming steroid drugs, as the powerful endocrine disruptors, are introduced since they are serious environmental contaminants.
Export Options
About this article
Cite this article as:
Tong Wang-Yu and Dong Xiang, Microbial Biotransformation: Recent Developments on Steroid Drugs, Recent Patents on Biotechnology 2009; 3 (2) . https://dx.doi.org/10.2174/187220809788700157
DOI https://dx.doi.org/10.2174/187220809788700157 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antidotes for Acute Cyanide Poisoning
Current Pharmaceutical Biotechnology Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis
Current Vascular Pharmacology Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
Current Medicinal Chemistry Free Radicals Generated by Post-Prandial Oxidative Burst in the Early Alterations of Vascular Contractility
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Anorexia Nervosa and the Use of Total Parenteral Nutrition Refeeding
Current Nutrition & Food Science Indications for Adult and Pediatric Magnetic Resonance Imaging Gadolinium-Enhanced Cisternography and Myelography: Experience and Review of the Literature
Current Medical Imaging Heart Rate Variability Indexes in Dementia: A Systematic Review with a Quantitative Analysis
Current Alzheimer Research Biochemical and Structural Investigations of Bothropstoxin-II, a Myotoxic Asp49 Phospholipase A2 from Bothrops jararacussu Venom
Protein & Peptide Letters Editorial [Hot Topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design TRPV4 Agonists and Antagonists
Current Topics in Medicinal Chemistry Microbial Efflux Pump Inhibition: Tactics and Strategies
Current Pharmaceutical Design 5'-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications
Current Medicinal Chemistry Post-cardiac Arrest Syndrome in Children
Current Pediatric Reviews Importance of ABC Transporters in Drug Development
Current Pharmaceutical Design Pulmonary Arterial Hypertension
Current Vascular Pharmacology A Catalytically Inactive Lys49 PLA2 Isoform from Bothrops jararacussu venom that Stimulates Insulin Secretion in Pancreatic Beta Cells
Protein & Peptide Letters DL-3-n-Butylphthalide, an Anti-Oxidant Agent, Prevents Neurological Deficits and Cerebral Injury Following Stroke per Functional Analysis, Magnetic Resonance Imaging and Histological Assessment
Current Neurovascular Research Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists
Current Topics in Medicinal Chemistry Microbial Polysaccharides and their Derivatives as Current and Prospective Pharmaceuticals
Current Pharmaceutical Design Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design